Professor Fai Ng
| CD40 ligand antagonist dazodalibep in Sjögren’s disease: a randomized, double-blinded, placebo-controlled, phase 2 trial | 2024 |
|
Professor Fai Ng
| Consensus gene modules strategy identifies candidate blood-based biomarkers for primary Sjögren's disease | 2024 |
|
Professor Fai Ng
| Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohorts | 2024 |
|
Professor Fai Ng
| Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study | 2024 |
|
Professor Fai Ng
| Serum and Tissue Biomarkers Associated With Composite of Relevant Endpoints for Sjögren Syndrome (CRESS) and Sjögren Tool for Assessing Response (STAR) to B Cell–Targeted Therapy in the Trial of Anti–B Cell Therapy in Patients With Primary Sjögren Syndrome (TRACTISS) | 2024 |
|
Professor Fai Ng
| The Sjögren's Working Group: The 2023 OMERACT meeting and provisional domain generation | 2024 |
|
Dr Tiago Costa Professor Stephen Rushton Dr Stuart Watson Professor Fai Ng
| Depression in Sjögren's syndrome mediates the relationship between pain, fatigue, sleepiness, and overall quality of life | 2023 |
|
Professor Fai Ng Professor Lynn Rochester
| Digital endpoints in clinical trials of Alzheimer’s disease and other neurodegenerative diseases: challenges and opportunities | 2023 |
|
Dr Jessica Tarn John Casement Lauren Scott Karl Wood Dr Dennis Lendrem et al. | Examining the biological pathways underlying clinical heterogeneity in Sjogren's syndrome: Proteomic and network analysis | 2023 |
|
Dr Chloe Hinchliffe Dr Rana Rehman Dan Jackson Dr Kristen Davies Victoria Macrae et al. | Identification of Fatigue and Sleepiness in Immune and Neurodegenerative Disorders from Measures of Real-World Gait Variability | 2023 |
|
Professor Fai Ng Dr Kyle Thompson
| Influence of exposure to climate-related hazards in the phenotypic expression of primary Sjögren's syndrome | 2023 |
|
Dr Christopher Bull Professor Fai Ng
| Reverse Engineering of Digital Measures: Inviting Patients to the Conversation | 2023 |
|
Dr Alan Bagnall Dr Steve Murray Dr Guy MacGowan Professor Fai Ng Dr Iain McKinnon et al. | Role of autonomic dysregulation in quality of life and functional impairment in implantable cardioverter defibrillator patients | 2023 |
|
Dr Jessica Tarn Emmanuella Traianos Amy Collins Dr Myrto Stylianou Dr Jehill Parikh et al. | The Effects Of Non-Invasive Vagus Nerve Stimulation on Fatigue In Participants With Primary Sjögren's Syndrome | 2023 |
|
Dr Emma Slack Professor Fai Ng
| Activity interference in patients with Sjögren’s syndrome: a cross-sectional study of 149 patients in the UK | 2022 |
|
Professor Fai Ng
| Addressing the clinical unmet needs in primary Sjögren's Syndrome through the sharing, harmonization and federated analysis of 21 European cohorts | 2022 |
|
Dr Rana Rehman Victoria Macrae Dr Kristen Davies Professor Fai Ng
| Assessing fatigue and sleep in chronic diseases using physiological signals from wearables: A pilot study | 2022 |
|
Dr Jessica Tarn Dr Dennis Lendrem Professor Michael Barnes John Casement Professor Fai Ng et al. | Comorbidities in the UK Primary Sjögren’s Syndrome Registry | 2022 |
|
Professor Fai Ng
| Genome-wide association study identifies Sjögren’s risk loci with functional implications in immune and glandular cells | 2022 |
|
Dr Jessica Tarn Dr Dennis Lendrem Dr Clare Lendrem Ben Hargreaves Professor Fai Ng et al. | Primary Sjögren's syndrome: Longitudinal real-world, observational data on health-related quality of life | 2022 |
|
Dr Jessica Tarn Professor Fai Ng
| Trained Immunity in Primary Sjögren’s Syndrome: Linking Type I Interferons to a Pro-Atherogenic Phenotype | 2022 |
|
Professor Fai Ng Dr Jessica Tarn
| Variability of Primary Sjögren's Syndrome Is Driven by Interferon α and Interferon α Blood Levels Are Associated With the Class II HLA–DQ Locus | 2022 |
|
Dr Dennis Lendrem Dr Jessica Tarn Professor James Wason Professor Fai Ng
| Why stratification is important in primary Sjögren’s syndrome | 2022 |
|
Dr Kristen Davies Professor Fai Ng
| Autonomic Nervous System Dysfunction in Primary Sjögren’s Syndrome | 2021 |
|
Dr Fiona Rayner Dr Amy Anderson Dr Ken Baker Professor Christopher Buckley Dr Bernard Dyke et al. | BIOlogical Factors that Limit sustAined Remission in rhEumatoid arthritis (the BIO-FLARE study): protocol for a non-randomised longitudinal cohort study | 2021 |
|
Dr Kristen Davies Professor Fai Ng
| Fatigue in inflammatory rheumatic diseases: current knowledge and areas for future research | 2021 |
|
Professor Fai Ng
| Genetic variants at the RTP4/MASP1 locus are associated with fatigue in Scandinavian patients with primary Sjögren's syndrome | 2021 |
|
Dr Jessica Tarn John Casement Dr Peter Gallagher Dr Deborah Wilson Dr Francesca Barone et al. | Improvement of Severe Fatigue Following Nuclease Therapy in Patients With Primary Sjögren's Syndrome: A Randomized Clinical Trial | 2021 |
|
Professor Fai Ng
| Influence of the age at diagnosis in the disease expression of primary Sjögren syndrome. Analysis of 12,753 patients from the Sjögren Big Data Consortium | 2021 |
|
Dr Nishanthi Thalayasingam Professor Fai Ng
| New developments in Sjogren's syndrome | 2021 |
|
Professor Fai Ng
| Reply | 2021 |
|
Dr Alexis Collins Dr Dennis Lendrem Professor James Wason Dr Jessica Tarn Dr Nadia Howard-Tripp et al. | Revisiting the JOQUER trial: stratification of primary Sjögren’s syndrome and the clinical and interferon response to hydroxychloroquine | 2021 |
|
Dr Arthur Pratt Dr Stefan Siebert Mike Cole Dr Deborah Stocken Amy Cranston et al. | Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trial | 2021 |
|
Professor Fai Ng
| The management of Sjögren's syndrome: British Society for Rheumatology guideline scope | 2021 |
|
Mike Cole Professor Fai Ng Dr Stefan Siebert Dr Arthur Pratt Professor John Isaacs et al. | TRAFIC: statistical design and analysis plan for a pragmatic early phase 1/2 Bayesian adaptive dose escalation trial in rheumatoid arthritis | 2021 |
|
Professor Fai Ng
| Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study | 2020 |
|
Professor Fai Ng
| EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies | 2020 |
|
Kristen Davies Dr Alexis Collins Dr Fraser Charlton Professor Fai Ng
| Nodular localized primary cutaneous amyloidosis and primary Sjögren’s syndrome | 2020 |
|
Emmanuella Traianos Dr James Locke Dr Dennis Lendrem Ben Hargreaves Dr Jessica Tarn et al. | Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sjögren’s syndrome | 2020 |
|
Professor Fai Ng
| Systemic phenotype related to primary Sjögren's syndrome in 279 patients carrying isolated anti-La/SSB antibodies | 2020 |
|
Dr Stefan Siebert Dr Arthur Pratt Dr Deborah Stocken Dr Miranda Patterson Amy Cranston et al. | Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition: An early phase trial | 2020 |
|
Professor Fai Ng
| Vagus nerve stimulation for autoimmune rheumatic diseases | 2020 |
|
Professor Fai Ng
| Weight of salivary gland ultrasonography compared to other items of the 2016 ACR/EULAR classification criteria for Primary Sjögren’s syndrome | 2020 |
|
Dr Ieuan Lewis Dr Kate Hackett Professor Fai Ng Emerita Professor Julia Newton
| A two-phase cohort study of the sleep phenotype within primary Sjögren's syndrome and its clinical correlates | 2019 |
|
Dr Clare Lendrem Dr Dennis Lendrem Dr Arthur Pratt Najib Naamane Dr Peter McMeekin et al. | Between a ROC and a hard place: Teaching prevalence plots to understand real world biomarker performance in the clinic | 2019 |
|
Kristen Davies Dr Kamran Mirza Dr Jessica Tarn Dr Nadia Howard-Tripp Dr Dennis Lendrem et al. | Fatigue in primary Sjögren’s syndrome (pSS) is associated with lower levels of proinflammatory cytokines: a validation study | 2019 |
|
Dr Dennis Lendrem Professor Fai Ng Dr Kate Hackett
| Managing fatigue in patients with primary Sjögren’s syndrome: challenges and solutions | 2019 |
|
Dr Dennis Lendrem Professor Fai Ng Dr Kate Hackett
| Managing fatigue in patients with primary Sjögren's syndrome. | 2019 |
|
Dr Cara Tomas Dr Ilse Pienaar Vicki Strassheim Professor Fai Ng Emerita Professor Julia Newton et al. | MtDNA population variation in Myalgic encephalomyelitis/Chronic fatigue syndrome in two populations: a study of mildly deleterious variants | 2019 |
|
James Clark Professor Fai Ng Professor Stephen Rushton Dr Stuart Watson Emerita Professor Julia Newton et al. | Network structure underpinning (dys) homeostasis in chronic fatigue syndrome; Preliminary findings | 2019 |
|
Dr Kate Hackett Kristen Davies Dr Jessica Tarn Ben Hargreaves Dr Dennis Lendrem et al. | Pain and depression are associated with both physical and mental fatigue independently of comorbidities and medications in primary Sjögren's syndrome | 2019 |
|
Professor Fai Ng Dr Joseph Guadagno
| Positive anti-MOG antibodies in a patient with Sjögren's syndrome and transverse myelitis | 2019 |
|
Professor Fai Ng Dr Dennis Lendrem Professor Mike Trenell
| Supervised walking improves cardiorespiratory fitness, exercise tolerance, and fatigue in women with primary Sjögren’s syndrome: a randomized-controlled trial | 2019 |
|
Dr Jessica Tarn Dr Nadia Howard-Tripp Dr Dennis Lendrem Andrew Skelton Dr Katherine James et al. | Symptom-based stratification of patients with primary Sjögren's syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised clinical trials | 2019 |
|
Dr Jessica Tarn Sarah Legg Sheryl Mitchell Professor Fai Ng
| The Effects of Noninvasive Vagus Nerve Stimulation on Fatigue and Immune Responses in Patients With Primary Sjögren's Syndrome | 2019 |
|
Dr Hanaa Rajabally Professor Fai Ng
| Anti-Ro antibodies and complete heart block in adults with Sjögren’s syndrome | 2018 |
|
Dr Katherine James Dr Simon Cockell Dr Colin Gillespie Dr Jennifer Hallinan Dr Francesca Barone et al. | B-cell activity markers are associated with different disease activity domains in primary Sjögren's syndrome | 2018 |
|
Professor Fai Ng
| CD40 as a therapeutic target in Sjögren’s syndrome | 2018 |
|
Professor Fai Ng Dr Katherine James Dr Bridget Griffiths Dr David Coady Dr Steven Young-Min et al. | Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren's syndrome: Examination of data from the UK Primary Sjögren's Syndrome Registry | 2018 |
|
Professor Fai Ng
| Effect of rituximab on a salivary gland ultrasound score in primary Sjögren's syndrome: results of the TRACTISS randomised double-blind multicentre substudy | 2018 |
|
Dr Kate Hackett Vincent Deary Emerita Professor Julia Newton Professor Fai Ng Professor Tim Rapley et al. | Experience of sleep disruption in primary Sjögren’s syndrome: A focus group study | 2018 |
|
Professor Fai Ng
| How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: Analysis of 10,500 patients (Sjögren Big Data Project) | 2018 |
|
Dr Kate Hackett Dr Katherine Deane Emerita Professor Julia Newton Vincent Deary Professor Tim Rapley et al. | Mixed-Methods Study Identifying Key Intervention Targets to Improve Participation in Daily Living Activities in Primary Sjögren's Syndrome Patients | 2018 |
|
Dr Laura Maclachlan Dr Andreas Finkelmeyer James Clark Dr James Locke Dr Stephen Todryk et al. | Reduction of Glucocorticoid Receptor Function in Chronic Fatigue Syndrome | 2018 |
|
Shereen Al-Ali Dr Jessica Tarn Dr Dennis Lendrem Dr Bridget Griffiths Professor Fai Ng et al. | Systemic interferon type I and type II signatures in primary Sjögren’s syndrome reveal differences in biological disease activity | 2018 |
|
Dr James Locke Dr Bridget Griffiths Professor Fai Ng
| A new MHC-linked susceptibility locus for primary Sjögren's syndrome: MICA | 2017 |
|
Dr Katie Hackett Dr Zoe Gotts Dr John Ellis Vincent Deary Dr Tim Rapley et al. | An investigation into the prevalence of sleep disturbances in primary Sjögren’s syndrome: a systematic review of the literature | 2017 |
|
Charlotte Hemingbrough Professor Fai Ng Professor Robert Taylor Emerita Professor Julia Newton Dr Joanna Elson et al. | Clinically proven mtDNA mutations are not common in those with chronic fatigue syndrome | 2017 |
|
Professor Fai Ng
| Corrigendum: Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements [Rheumatology, 54, (2015) (2230-2238)] DOI: 10.1093/rheumatology/kev200 | 2017 |
|
Sheryl Mitchell Dr Katherine James Professor Fai Ng Dr Bridget Griffiths Vicki Hindmarsh et al. | Corrigendum: Eligibility for clinical trials in primary Sjögren's syndrome: Lessons from the UK Primary Sjögren's Syndrome Registry [Rheumatology, 55, (2016) (544-552)] doi:10.1093/rheumatology/kev373 | 2017 |
|
Professor Fai Ng
| Identification of a Sjögren's syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons | 2017 |
|
Professor Fai Ng Ariana Miller Dr Steven Young Min Dr David Coady Dr Bridget Griffiths et al. | Physical activity but not sedentary activity is reduced in primary Sjögren’s syndrome | 2017 |
|
Dr Alexandra Battersby Gladys - Dr Jessica Tarn Professor Fai Ng Professor Andrew Gennery et al. | Raised Serum IL-8 Levels Are Associated with Excessive Fatigue in Female Carriers of X-Linked Chronic Granulomatous Disease in the UK | 2017 |
|
Professor Fai Ng
| Randomized Controlled Trial of Rituximab and Cost-Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome | 2017 |
|
Professor Fai Ng
| Rare X Chromosome Abnormalities in Systemic Lupus Erythematosus and Sjögren's Syndrome | 2017 |
|
Andrew Carr Professor Fai Ng
| Salivary gland ultrasound abnormalities in primary Sjögren's syndrome: Consensual US-SG core items definition and reliability | 2017 |
|
Professor Fai Ng
| Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren's syndrome | 2017 |
|
Dr Peter Gallagher Sheryl Mitchell Dr Bridget Griffiths Vicki Hindmarsh Ben Hargreaves et al. | Subjective and Objective Measures of Dryness Symptoms in Primary Sjögren’s Syndrome – Capturing the discrepancy | 2017 |
|
Dr Katie Hackett Dr Francesca Barone Professor Fai Ng
| The British Society for Rheumatology guideline for the management of adults with primary Sjögren's Syndrome | 2017 |
|
Ruth Hart Professor Fai Ng Emerita Professor Julia Newton Dr Katie Hackett Dr Richard Lee et al. | What impact does written information about fatigue have on patients with autoimmune rheumatic diseases? Findings from a qualitative study | 2017 |
|
Dr Nadia Howard-Tripp Dr Jessica Tarn Dr Colin Gillespie Dr Dennis Lendrem Dr Bridget Griffiths et al. | A Cytokine-Mediated Biological Basis for Fatigue in Primary Sjögren’s Syndrome | 2016 |
|
Professor Fai Ng
| Defining disease activity states and clinically meaningful improvement in primary Sjogren's syndrome with EULAR primary Sjogren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI) | 2016 |
|
Professor Fai Ng
| Early diagnosis of primary Sjogren's syndrome: EULAR-SS task force clinical recommendations | 2016 |
|
Sheryl Mitchell Dr Katherine James Professor Fai Ng Dr Bridget Griffiths Vicki Hindmarsh et al. | Eligibility for clinical trials in primary Sjogren's syndrome: lessons from the UK Primary Sjogren's Syndrome Registry | 2016 |
|
Dr Jessica Tarn Andini Natasari Colin Gillespie Sheryl Mitchell Dr Katie Hackett et al. | Fatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokines | 2016 |
|
Dr Jessica Tarn Dr James Locke Professor Fai Ng
| Germline variation of TNFAIP3 in primary Sjögren's syndrome-associated lymphoma | 2016 |
|
Professor Fai Ng
| Klinefelter's syndrome (47,XXY) is in excess among men with Sjögren's syndrome | 2016 |
|
Dr Katie Hackett Dr Dennis Lendrem Ben Hargreaves Vicki Strassheim Dr Zoe Gotts et al. | Objective Improvement in Fatigue Scores for Primary Sjögren’s Patients Receiving a Tailored Multidisciplinary Fatigue Intervention in a Generic Fatigue Clinic | 2016 |
|
Professor Fai Ng
| Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjögren's Syndrome | 2016 |
|
Professor Fai Ng
| T Cell Targeting Therapies for Sjorgren's Syndrome | 2016 |
|
James Clark Professor Fai Ng Dr Stuart Watson Emerita Professor Julia Newton
| The aetiopathogenesis of fatigue: unpredictable, complex and persistent | 2016 |
|
Ruth Hart Dr Katie Hackett Rob Newton Professor Fai Ng Dr Ben Thompson et al. | The F-Word: Why Is Talking about Fatigue so Hard? | 2016 |
|
Professor Fai Ng
| X Chromosome Dose and Sex Bias in Autoimmune Diseases: Increased Prevalence of 47,XXX in Systemic Lupus Erythematosus and Sjogren's Syndrome | 2016 |
|
Dr Katie Hackett Dr Dennis Lendrem Dr Tim Rapley Dr Katherine Deane Vincent Deary et al. | "Doing Every-Day Life" with Primary Sjogren's Syndrome: Factors Predicting Difficulties Performing Daily Activities and Taking on Life Roles | 2015 |
|
Andrew Carr Professor Fai Ng
| A New Scoring System for Ultrasonographic Evaluation of Salivary Gland in Sjogren: Multireader Reliability | 2015 |
|
Dr Katie Hackett Dr Katherine Deane Vicki Strassheim Vincent Deary Dr Tim Rapley et al. | A Systematic Review of Non-Pharmacological Interventions for Primary Sjögren's Syndrome. | 2015 |
|
Dr Katherine James Shereen Al-Ali Dr Jessica Tarn Dr Simon Cockell Dr Colin Gillespie et al. | A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjögren’s Syndrome | 2015 |
|
Jessica Tarn Dr Simon Cockell Dr Colin Gillespie Emerita Professor Julia Newton Professor Anil Wipat et al. | A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjögren's Syndrome | 2015 |
|
Ben Hargreaves Dr Dennis Lendrem Vicki Hindmarsh Claire Humphrey Sheryl Mitchell et al. | Assignable Causes for Fatigue in Primary Sjögren’s Syndrome: Data from the UK Primary Sjögren’s Syndrome Registry | 2015 |
|
Professor Fai Ng
| Characterization of systemic disease in primary Sjogren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements | 2015 |
|
Dr Katie Hackett Dr Dennis Lendrem Dr James Frith Dr Tim Rapley Vincent Deary et al. | Cognitive Impairment in Primary Sjögren’s Syndrome | 2015 |
|
Dr Katie Hackett Dr Dennis Lendrem Dr James Frith Dr Tim Rapley Vincent Deary et al. | Cognitive Symptoms are Common in Primary Sjogren's Syndrome and are Associated with Anxiety | 2015 |
|
Dr Katie Hackett Dr Dennis Lendrem Dr James Frith Dr Tim Rapley Vincent Deary et al. | Cognitive symptoms are common in primary Sjögren's syndrome and are associated with anxiety | 2015 |
|
Dr Dennis Lendrem Sheryl Mitchell Dr Peter McMeekin Dr Katie Hackett Sarah Bowman et al. | Do the EULAR Sjögren’s syndrome outcome measures correlate with health status in primary Sjögren’s syndrome? | 2015 |
|
Professor Fai Ng Dr Katherine James Dr Bridget Griffiths Dr James Andrews Dr Vadivelu Saravanan et al. | Eligibility for Clinical Trials in Primary Sjogren's Syndrome: Lessons from the UK Primary Sjogren's Registry | 2015 |
|
Shereen Al-Ali Dr Jessica Tarn Dr Simon Cockell Dr Colin Gillespie Professor John Isaacs et al. | Gene Set Enrichment Analysis Across Multiple Expression Studies Reveals a Core Subset of Primary Sjögren's Syndrome-Related Genes | 2015 |
|
Professor Fai Ng
| Identification of Novel Sjogren's Syndrome Risk Loci in the Regions of TNFAIP3 and PRDM1 | 2015 |
|
Shereen Al-Ali Dr Simon Cockell Dr Jessica Tarn Dr Katherine James Sarah Bowman et al. | Identification of Whole Blood Gene Expression Signature in Primary Sjogren's Syndrome Associated Lymphoma | 2015 |
|
Dr Katie Hackett Joanne Newton Dr Tim Rapley Vincent Deary Professor Niina Kolehmainen et al. | Identifying participation barriers and key intervention targets for an autoimmune disease | 2015 |
|
Dr Katie Hackett Dr Tim Rapley Professor Niina Kolehmainen Vincent Deary Dr Katherine Deane et al. | Identifying stakeholder informed priority targets for a non-pharmacological intervention package to improve functional capacity: a multi-centre mixed methods study | 2015 |
|
Dr Katie Hackett Dr Katherine Deane Dr Tim Rapley Vincent Deary Sarah Bowman et al. | Identifying Targets for a Non-Pharmacological Therapy Intervention Package to Improve Participation in Primary Sjögren's Syndrome Patients: A Group Concept Mapping Study | 2015 |
|
Dr Francesca Barone Professor Fai Ng
| Integrated International Collaborations in Sjogren's Syndrome: The Essential (EULAR Sjogren's Syndrome Experimental and Translational Investigative Alliance) Study Group | 2015 |
|
Professor Fai Ng Professor Anil Wipat Dr Jennifer Hallinan
| Integrative Network-Based Analysis of the Primary Sjogren's Syndrome Transcriptome between Human and Mouse | 2015 |
|
Professor Fai Ng
| Klinefelter's Syndrome (47,XXY) Among Men with Sjogren's Syndrome | 2015 |
|
Professor Fai Ng Dr Jennifer Hallinan
| Machine Learning of Fatigue-Related Clinical Features in Primary Sjogren's Syndrome | 2015 |
|
Professor Fai Ng Professor Mike Trenell
| Oxygen Uptake, Fatigue and Quality of Life in Primary Sjogren's Syndrome | 2015 |
|
Dr Jessica Tarn Dr Dennis Lendrem Dr Colin Gillespie Shereen Al-Ali Dr Bridget Griffiths et al. | Patient Sub-Phenotyping in Primary Sjogren's Syndrome | 2015 |
|
Professor Fai Ng
| Preliminary Results of a Double-Blind Randomised Trial of Rituximab Anti-B-Cell Therapy in Patients with Primary Sjogrens Syndrome | 2015 |
|
Dr Faye Cooles Dr Arthur Pratt Dr Dennis Lendrem Professor Fai Ng Dr Terry Aspray et al. | Retrospective analysis of the role of serum vitamin D in early rheumatic disease | 2015 |
|
Dr Simon Cockell Dr Colin Gillespie Professor Fai Ng
| Serum Free Light Chains are Associated with Clinical Disease Activity of Primary Sjögren's Syndrome in the Cutaneous, Biological and Renal Domains | 2015 |
|
Professor Fai Ng
| Systemic Interferon Type I and Type II Signatures Present in Distinct Subsets of Primary Sjogren's Syndrome: En Route Towards More Selective Targeting | 2015 |
|
Professor Fai Ng
| The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share | 2015 |
|
Professor Fai Ng
| Validation of EULAR primary Sjogren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI) | 2015 |
|
Dr Katie Hackett Dr Katherine Deane Vincent Deary Emerita Professor Julia Newton Professor Tim Rapley et al. | A Systematic Review of Non-Pharmacological Interventions for Primary Sjögren's Syndrome | 2014 |
|
Dr Rebecca Batten Professor Fai Ng
| An Audit of New Patient Referrals to A Dedicated Primary SjÖGren's Syndrome Clinic | 2014 |
|
Dr Rebecca Batten Professor Fai Ng
| An overview of the clinical manifestations and management of primary Sjögren's syndrome | 2014 |
|
Dr Simon Cockell Dr Colin Gillespie Professor Fai Ng
| Baff and B2m, but not Free Light Chains, Correlate with Disease Activity in Primary Sjögren's Syndrome (PSS) | 2014 |
|
Sheryl Mitchell Dr Bridget Griffiths Professor Fai Ng
| Cardiovascular Risk Factors in Women With Primary Sjögren's Syndrome: United Kingdom Primary Sjögren's Syndrome Registry Results | 2014 |
|
Dr Katie Hackett Emerita Professor Julia Newton Dr Katherine Deane Dr Tim Rapley Vincent Deary et al. | Developing a service user informed intervention to improve participation and ability to perform daily activities in primary Sjӧgren’s syndrome: a mixed methods study protocol | 2014 |
|
Siobhan Crittenden Dr Elizabeth Coulson Professor Vijay Kunadian Professor Fai Ng Emerita Professor Helen Foster et al. | Elevated Cardiovascular Disease Burden and Inflammatory Biomarker Levels in Adults with Juvenile Idiopathic Arthritis | 2014 |
|
Dr Rebecca Batten Professor Fai Ng
| Facial nerve compression by the posterior inferior cerebellar artery causing facial pain and swelling: A case report | 2014 |
|
Dr Dennis Lendrem Sheryl Mitchell Dr Peter McMeekin Dr Bridget Griffiths Professor Fai Ng et al. | Health-related utility values of patients with primary Sjögren's syndrome and its predictors | 2014 |
|
Shereen Al-Ali Dr Simon Cockell Andrew Skelton Dr Katherine James Dr Jessica Tarn et al. | Identification of Whole Blood Gene Expression Signature in Primary Sjogren's Syndrome Associated Lymphoma | 2014 |
|
Professor Fai Ng Dr James Miller
| Idiopathic axonal neuropathy and primary Sjögren's syndrome | 2014 |
|
Dr Katherine James Dr Jessica Tarn Shereen Al-Ali Dr Jennifer Hallinan Professor David Young et al. | Integration of Gene Expression Data with Interaction and Annotation Data Reveals Patterns of Connection Between Primary Sjögren’s Syndrome Associated Genes and Immune Processes | 2014 |
|
Dr Jane Falconer Katie Lowes Professor Fai Ng Professor John Robinson
| Intramolecular polyspecificity in CD4 T-cell recognition of Ad-restricted epitopes of proteoglycan aggrecan | 2014 |
|
Dr Katie Hackett Dr Katherine Deane Vincent Deary Dr Tim Rapley Emerita Professor Julia Newton et al. | Non-Pharmacological Interventions for Primary Sjogren's Syndrome: A Systematic Review of the Evidence | 2014 |
|
Dr Kate Hackett Vincent Deary Professor Tim Rapley Emerita Professor Julia Newton Professor Fai Ng et al. | Non-Pharmacological Interventions for Primary Sjögren's Syndrome: A Systematic Review of the Evidence | 2014 |
|
Dr James Frith Professor Fai Ng Professor Chris Day Dr Brendan Payne Professor Neil Sheerin et al. | Orthostatic intolerance is common in chronic disease - A clinical cohort study | 2014 |
|
Dr Faye Cooles Dr Arthur Pratt Dr Dennis Lendrem Professor Fai Ng Dr Terry Aspray et al. | Retrospective analysis of the role of serum vitamin D in early rheumatic disease | 2014 |
|
Dr Katie Hackett Emerita Professor Julia Newton Dr Tim Rapley Dr Katherine Deane Vincent Deary et al. | Systematic reviews of occupational therapy interventions: summarizing research evidence and highlighting the gaps | 2014 |
|
Dr Katherine James Dr Dennis Lendrem Sheryl Mitchell Vicki Hindmarsh Dr David Coady et al. | The UK Primary Sjögren’s Syndrome Registry (UKPSSR): A Valuable Resource for Future Sjögren’s Syndrom Research | 2014 |
|
Dr Katie Hackett Professor Fai Ng Dr Peter Gallagher
| Understanding the Gap between Subjective Symptoms and Objective Illness Markers in Primary Sjogren's Syndrome | 2014 |
|
Dr Jessica Tarn Dr Simon Cockell Dr Colin Gillespie Shereen Al-Ali Dr Katherine James et al. | Whole Blood microRNA Signature for Primary Sjogren's Syndrome-Related Lymphoma | 2014 |
|
Dr Karthik Balasubramaniam Dr Girish Viswanathan Andini Natasari Jessica Tarn Dr Dennis Lendrem et al. | Assessment of blood clot formation and platelet receptor function ex vivo in patients with primary Sjögren’s syndrome | 2013 |
|
Professor Fai Ng Andrew Carr Dr Ian Corbett Professor Marco Carrozzo Dr Dennis Lendrem et al. | Association of genes in the NF-κB pathway with antibody-positive primary Sjögren's syndrome. | 2013 |
|
Dr Elizabeth Coulson Professor Fai Ng Emerita Professor Helen Foster
| Cardiovascular Risk In Adults With Juvenile Idiopathic Arthritis | 2013 |
|
Professor Fai Ng Dr Iain Goff Emerita Professor Helen Foster
| Cardiovascular risk in juvenile idiopathic arthritis | 2013 |
|
Dr Mohsen Elshahaly Gill Wheater Dr Stephen Tuck Dr Harish Datta Professor Fai Ng et al. | Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, a B cell depleting monoclonal antibody (HORUS TRIAL) | 2013 |
|
Professor Fai Ng
| Complex Functional Effects Within The HLA Contribute To Sjogren's Syndrome Pathogenesis and May Influence Both Transcriptional Regulation and Peptide Binding | 2013 |
|
Andini Natasari Jessica Tarn Dr Dennis Lendrem Professor Fai Ng
| Exploring the biological basis of fatigue using primary Sjögren's syndrome as a disease model | 2013 |
|
Professor Fai Ng
| Identification of Multiple Sjögren’s Syndrome Susceptibility Loci | 2013 |
|
Professor Fai Ng Professor Mike Trenell
| Level of Physical Activity in Primary Sjögren's Syndrome and its Predictors | 2013 |
|
Professor Fai Ng
| Sex Bias In Autoimmune Diseases: Increased Risk Of 47,XXX In Systemic Lupus Erythematosus (SLE) and Sjogren's Syndrome (SS) Supports The Gene Dose Hypothesis | 2013 |
|
Dr Faye Cooles Dr Arthur Pratt Professor Fai Ng Dr Terry Aspray Professor John Isaacs et al. | The Effect Of Vitamin D On Early Rheumatoid Arthritis: A Retrospective Cohort Analysis | 2013 |
|
Professor Fai Ng
| Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome | 2013 |
|
Professor Fai Ng
| A Genome-Wide Association Study Establishes Muliple Susceptibility Loci for Sjogren's Syndrome | 2012 |
|
Emerita Professor Julia Newton Dr James Frith Danielle Powell Dr Katie Hackett Katharine Wilton et al. | Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjögren's syndrome | 2012 |
|
Dr Dennis Lendrem Sheryl Mitchell Sarah Bowman Dr Bridget Griffiths Heather Foggo et al. | Evaluating health status of 620 patients with primary sjögren’s syndrome using EQ-5D | 2012 |
|
Professor Fai Ng Dr Dennis Lendrem Sarah Bowman
| Evaluating health status of 620 patients with primary Sjögren's syndrome using EQ-5D | 2012 |
|
Professor Fai Ng Dr Dennis Lendrem
| How good are the EULAR Sj ögren's syndrome disease activity index (ESSDAI), and EULAR Sj ögren's syndrome patients reported index (ESSPRI) in predicting health status in primary Sj ögren's syndrome? Normal 0 false false false EN-GB X-NONE X-NONE Normal 0 false false false EN-GB X-NONE X-NONE Normal 0 false false false EN-GB X-NONE X-NONE | 2012 |
|
Dr Dennis Lendrem Sheryl Mitchell Sarah Bowman Dr David Coady Dr Bridget Griffiths et al. | How good are the eular sjögren’s syndrome disease activity index, and eular sjögren’s syndrome patients reported index in predicting health status in primary sjögren’s syndrome? | 2012 |
|
Dr Katie Hackett Emerita Professor Julia Newton Professor Fai Ng
| Occupational therapy: a potentially valuable intervention for people with primary Sjogren's syndrome | 2012 |
|
Sheryl Mitchell Dr Bridget Griffiths Professor Fai Ng
| Potential diagnostic utility of anti-centromere antibody in primary Sjogren's syndrome in the UK | 2012 |
|
Professor Fai Ng Katharine Wilton Sheryl Mitchell Emerita Professor Julia Newton
| Primary Sjogrens syndrome is associated with impaired autonomic response to orthostasis and sympathetic failure | 2012 |
|
Professor Fai Ng
| Primary Sjogren's Syndrome Research and Therapy: Has a New Dawn Arrived? | 2012 |
|
Dr Jessica Tarn Professor David Young Dr Dennis Lendrem Christine Downie Heather Foggo et al. | Serum cytokine and chemokine profiling in primary Sj ögren's syndrome Normal 0 false false false EN-GB X-NONE X-NONE | 2012 |
|
Andrew Carr Professor Fai Ng Professor Francisco Figueiredo Dr Iain Macleod Professor Mark Greenwood et al. | Sjogren's syndrome - an update for dental practitioners | 2012 |
|
Jessica Tarn Andini Natasari Sheryl Mitchell Dr Dennis Lendrem Christine Downie et al. | Soluble molecule profiling and network analysis of primary Sjogren's syndrome patient serum | 2012 |
|
Sheryl Mitchell Dr David Coady Dr Bridget Griffiths Dr Dennis Lendrem Heather Foggo et al. | The clinical relevance of anti-RO52 and anti-RO60 in patients in the united kingdom primary sjögren’s syndrome registry (UKPSSR) | 2012 |
|
Andrew Carr Professor Fai Ng
| The diagnostic utility of salivary gland ultrasound for the investigation of sjögren's syndrome | 2012 |
|
Professor Fai Ng
| A High-Density Genome-Wide Association Study by the Sjogren's Genetics Network Identifies Five Novel Susceptibility Loci for Primary Sjogren's Syndrome and Confirms Association with MHC, IRF5, and BLK | 2011 |
|
Professor Fai Ng
| Biological therapies in primary Sjogren's syndrome | 2011 |
|
Professor Fai Ng Dr Susan Tudhope Dr Alexei von Delwig Dr Desa Lilic
| Invariant natural killer T (iNKT) cell deficiency in chronic mucocutaneous candidiasis - A consequence or a cause? | 2011 |
|
Professor Fai Ng
| Large-Scale, High-Density Genotyping Performed by the Sjogren's Genetics Network Using the ImmunoChip Identifies PRKRA as a Novel Sjogren's Syndrome Susceptibility Locus and Confirms Associations with IRF5, BLK and MHC | 2011 |
|
Emerita Professor Julia Newton Sheryl Mitchell Dr Bridget Griffiths Professor Fai Ng
| Potentially treatable symptoms in primary Sjogren's Syndrome - Associated fatigue | 2011 |
|
Dr Faye Cooles Dr Arthur Pratt Dr Gillian Wilson Professor John Isaacs Professor Fai Ng et al. | Prevalence and diagnostic outcome relating to vitamin D deficiency in new patients presenting to an early arthritis clinic over 12 months | 2011 |
|
Professor Fai Ng
| Prevalence of traditional cardiovascular risk factors in females with primary Sjogrens Syndrome | 2011 |
|
Professor Fai Ng
| Triple X Syndrome (47,XXX) Increases the Risk and Accelerates the Onset of Systemic Lupus Erythematosus and Sjogren's Syndrome: Support for a Gene-Dose Effect From the X Chromosome | 2011 |
|
Professor Fai Ng Dr Bridget Griffiths Professor Marco Carrozzo
| United Kingdom Primary Sjogren's Syndrome Registry - a united effort to tackle an orphan rheumatic disease | 2011 |
|
Professor Fai Ng Professor John Isaacs
| Genotype at the sIL-6R A358C polymorphism does not influence response to anti-TNF therapy in patients with rheumatoid arthritis | 2010 |
|
Professor Fai Ng Dr Alexei von Delwig Dr Andrew Carmichael Dr Mario Abinun Professor Andrew Cant et al. | Impaired TH17 responses in patients with chronic mucocutaneous candidiasis with and without autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy | 2010 |
|
Professor Fai Ng
| Primary Sjogren's syndrome: too dry and too tired | 2010 |
|
Dr Susan Tudhope Dr Alexei von Delwig Dr Jane Falconer Dr Arthur Pratt Professor John Isaacs et al. | Profound invariant natural killer T-cell deficiency in inflammatory arthritis | 2010 |
|
Dr Alexei von Delwig James Locke Professor John Robinson Professor Fai Ng
| Response of Th17 Cells to a Citrullinated Arthritogenic Aggrecan Peptide in Patients With Rheumatoid Arthritis | 2010 |
|
Dr Claire Bracewell Professor John Isaacs Professor Fai Ng
| Atacicept, a novel B cell-targeting biological therapy for the treatment of rheumatoid arthritis | 2009 |
|
Julie Diboll Professor John Isaacs Professor Fai Ng
| CD4+T Cell Responses to Autoantigens in Patients with Rheumatoid Arthritis | 2009 |
|
Professor Fai Ng
| Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk | 2009 |
|
Dr Alexei von Delwig James Locke Professor John Robinson Professor Fai Ng
| T cell responses to citrullinated aggrecan peptide in rheumatoid arthritis | 2009 |
|
Jane Falconer Professor Fai Ng Professor John Robinson
| Type A and type B T cell recognition of an arthritogenic CD4 T cell epitope from proteoglycan aggrecan studied in mice | 2009 |
|
Dr Iain Brownlee Dr Alison Young Emeritus Professor Chris Seal Professor Fai Ng
| Diet and rheumatoid arthritis (RA) disease activity | 2008 |
|
Professor Fai Ng
| Expansion of hepatitis C-specific CD4+CD25+ regulatory T cells after viral clearance: A mechanism to limit collateral damage? | 2008 |
|
Professor Fai Ng Dr Alexei von Delwig Dr Andrew Carmichael Dr Mario Abinun Dr Desa Lilic et al. | Impaired Th-17 responses in patients with chronic mucocutaneous candidiasis | 2008 |
|
Dr Alexei von Delwig Professor Fai Ng Dr Andrew Carmichael Dr Mario Abinun Dr Desa Lilic et al. | Impaired Th-17 responses in patients with chronic mucocutaneous candidiasis | 2008 |
|
Dr Alexei von Delwig Dr Arthur Pratt Dr Susan Tudhope Professor John Isaacs Professor Fai Ng et al. | Invariant natural killer T (iNKT) cells in early rheumatoid arthritis (RA) | 2008 |
|
Dr Harish Datta Professor Fai Ng Dr Stephen Tuck
| The cell biology of bone metabolism | 2008 |
|
Dr Alexei von Delwig Dr Susan Tudhope Dr Arthur Pratt Professor John Isaacs Dr Desa Lilic et al. | The role of invariant natural killer T (iNKT) cells in rheumatoid arthritis | 2008 |
|
Professor Fai Ng
| Fluoroquinolone-associated tendinopathy: A case report | 2007 |
|
Professor Fai Ng Professor John Isaacs
| From mice to men: the challenges of developing tolerance-inducing biological drugs for the clinic | 2007 |
|
Professor Fai Ng Professor John Isaacs
| From mice to men: the challenges of developing tolerance-inducing biological drugs for the clinic | 2007 |
|
Professor Fai Ng
| In vivo evidence for apoptosis in the bone marrow in systemic lupus erythematosus | 2007 |
|
Professor Fai Ng Ching Ng
| Takayasu's arteritis: a cause of prolonged arterial stiffness | 2006 |
|
Professor Fai Ng
| A case of eosinophilic enteritis and rheumatoid arthritis | 2005 |
|
Professor Fai Ng
| In vivo evidence for apoptosis in the bone marrow in SLE | 2005 |
|
Professor Fai Ng
| Quantitating Effector and Regulatory T Lymphocytes in Immune Responses by Limiting Dilution Analysis Modeling | 2005 |
|
Professor Fai Ng
| Takayasu's arteritis is associated with reduced aortic compliance | 2005 |
|
Professor Fai Ng
| [abstract] Cox II selective inhibitors versus traditional NSAIDS: are we using them appropriately? | 2004 |
|
Professor Fai Ng
| [abstract] Eosinophilic gastroenteritis and rheumatoid arthritis | 2004 |
|
Professor Fai Ng
| [abstract] Prevalence of cardiovascular risk factors in patients with rheumatoid arthritis | 2004 |
|
Professor Fai Ng
| [abstract] Mesenteric Inflammatory veno-occlusive disease | 2003 |
|
Professor Fai Ng
| Cutting Edge: CTLA-4 (CD152) Differentially Regulates Mitogen-Activated Protein Kinases (Extracellular Signal-Regulated Kinase and c-Jun N-Terminal Kinase) in CD4+ T Cells from Receptor/Ligand-Deficient Mice | 2002 |
|
Professor Fai Ng
| Human CD4+ CD25+ T cells regulate CD8+ T-cell activation | 2002 |
|
Professor Fai Ng Dr Rachel Baker Dr Bill Chaudhry
| Reversibility with Interleukin-2 Suggests that T Cell Anergy Contributes to Donor-Specific Hyporesponsiveness in Renal Transplant Patients | 2002 |
|
Professor Fai Ng
| Dendritic cells in transplantation--friend or foe? | 2001 |
|
Professor Fai Ng Professor John Isaacs
| Human CD4+CD25+ cells: a naturally occurring population of regulatory T cells | 2001 |
|
Professor Fai Ng
| Infectious tolerance? Mechanisms and implications | 2001 |
|
Professor Fai Ng
| Predictive value of in vitro assessment of direct alloresponses in transplant recipients? (Comment on Transplantation. 2001 Sep 15;72(5):873-80) | 2001 |
|
Professor Fai Ng Dr Bill Chaudhry
| The role of T-cell anergy in the maintenance of donor-specific hyporesponsiveness in renal transplant recipients | 2001 |
|